Fresh Tracks Therapeutics Inc

General ticker "FRTX" information:

  • Sector: Health Care
  • Industry: Biotechnology
  • Capitalization: $4.3M

Fresh Tracks Therapeutics Inc does not follow the US Stock Market performance with the rate: -37.7%.

Estimated limits based on current volatility of 1.0%: low 0.74$, high 0.75$

Factors to consider:

  • Price in estimated range

Stock Forecast*

* forecast is subjective and experimental, should not be used for any investment decisions

Long term estimates were made for the period from 2023-12-31 to 2025-12-30

  • 2023-12-31 to 2024-12-30 estimated range: [0.61$, 1.80$]
  • 2024-12-30 to 2025-12-30 estimated range: [0.65$, 1.75$]

Financial Metrics affecting the FRTX estimates:

  • Negative: Non-GAAP EPS, $ of -1.41 <= 0.10
  • Negative: Operating profit margin, % of -44.27 <= 1.03
  • Negative: Operating cash flow per share per price, % of -46.78 <= 2.35
  • Negative: negative Net income
  • Positive: Investing cash flow per share, $ of 0 > -0.12
  • Negative: Industry operating profit margin (median), % of -98.30 <= 2.14

Similar symbols

Short-term FRTX quotes

Long-term FRTX plot with estimates

Financial data

YTD 2021-12-31 2022-12-31 2023-12-31
Operating Revenue $0.40MM $6.94MM $8.01MM
Operating Expenses $40.65MM $28.48MM $14.37MM
Operating Income $-40.24MM $-21.53MM $-6.36MM
Non-Operating Income $0.77MM $0.43MM $0.67MM
Interest Expense $0.07MM $0.01MM $0.01MM
R&D Expense $28.23MM $14.04MM $3.18MM
Income(Loss) $-39.47MM $-21.10MM $-5.69MM
Profit(Loss) $-39.47MM $-21.10MM $-5.69MM
Stockholders Equity $24.91MM $7.19MM $9.93MM
Inventory $0.12MM $0.50MM $0.00MM
Assets $29.72MM $10.27MM $11.59MM
Operating Cash Flow $-36.15MM $-19.34MM $-4.34MM
Capital expenditure $0.04MM $0.05MM $0.00MM
Investing Cash Flow $-0.04MM $-0.05MM $0.00MM
Financing Cash Flow $32.95MM $1.18MM $6.53MM
Earnings Per Share* $-22.14 $-7.36 $-0.96

* EPS are Split Adjusted, recent splits may be reflected with a delay.